Premier Path Wealth Partners, LLC Gilead Sciences, Inc. Transaction History
Premier Path Wealth Partners, LLC
- $643 Billion
- Q1 2025
A detailed history of Premier Path Wealth Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 8,864 shares of GILD stock, worth $965,378. This represents 0.15% of its overall portfolio holdings.
Number of Shares
8,864
Previous 8,052
10.08%
Holding current value
$965,378
Previous $744 Million
33.54%
% of portfolio
0.15%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,286Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.48 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.95 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.83 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...